Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein
- PMID: 1997469
- PMCID: PMC12200132
- DOI: 10.1007/BF01613195
Histogenesis of clear cell chondrosarcoma. An immunohistochemical study with osteonectin, a non-collagenous structure protein
Abstract
The histogenesis of clear cell chondrosarcoma is still unclear: Apart from typical clear cell tumor areas, extensive production of woven bone formation suggests within the clear cell cartilagenous stroma is an intriguing phenomenon. Three cases of clear cell chondrosarcoma documented in the Bone Tumor Registry of Westphalia were examined for their patterns of osteonectin expression, and compared with other bone tumors of either osseous or cartilaginous origin, and with normal cartilage tissue. Found predominantly in osseous structures, the protein osteonectin takes part in the formation of new bone. The three clear cell chondrosarcomas showed a strong immunoexpression of osteonectin in clear cell, chondroid and in osseous tumor areas. Similarly, evidence of osteonectin was also found in osteoblastic and in chondroblastic osteosarcomas as well as in osteoblastomas. In contrast, osteonectin could not be demonstrated in the chondrosarcomas and mesenchymal chondrosarcomas from our registry that were analysed for comparison, and was found only minimally in the fibroblastic areas of dedifferentiated chondrosarcomas. The chondroblastic tumor components were always negative. There was no immunoexpression of osteonectin either in fetal or adult intervertebral disc tissue. The present immunohistochemical study of osteonectin has distinctly separated clear cell chondrosarcoma from the other variants of chondrosarcoma, and aptly verified the specificity of this entity. Moreover, the study would call for further histogenetic evaluation of clear cell chondrosarcoma, since the pattern of osteonectin expression in that tumor seems to indicate an osteogenic rather than a chondrogenic origin.
Similar articles
-
Expression of membrane type 1 matrix metalloproteinase, matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 in human cartilaginous tumors with special emphasis on mesenchymal and dedifferentiated chondrosarcoma.J Cancer Res Clin Oncol. 1999 Oct;125(10):541-8. doi: 10.1007/s004320050314. J Cancer Res Clin Oncol. 1999. PMID: 10473866 Free PMC article.
-
Towards a new understanding and classification of chondrogenic neoplasias of the skeleton--biochemistry and cell biology of chondrosarcoma and its variants.Virchows Arch. 2002 Sep;441(3):219-30. doi: 10.1007/s00428-002-0641-x. Epub 2002 May 1. Virchows Arch. 2002. PMID: 12242518
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Is Dissection and Preservation of Adherent Popliteal Vessels From a Posterior Soft Tissue Mass Associated With a Higher Proportion of Local Recurrence in Patients With a Distal Femoral Osteosarcoma?Clin Orthop Relat Res. 2023 Nov 1;481(11):2167-2176. doi: 10.1097/CORR.0000000000002775. Epub 2023 Aug 1. Clin Orthop Relat Res. 2023. PMID: 37527334 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
Cited by
-
Clear cell chondrosarcoma is an underestimated tumor: Report of 7 cases and meta-analysis of the literature.J Bone Oncol. 2019 Oct 31;19:100267. doi: 10.1016/j.jbo.2019.100267. eCollection 2019 Dec. J Bone Oncol. 2019. PMID: 31788417 Free PMC article.
-
[Cartilage tumors: morphology, genetics, and current aspects of target therapy].Pathologe. 2020 Mar;41(2):143-152. doi: 10.1007/s00292-020-00752-5. Pathologe. 2020. PMID: 32060685 Review. German.
References
-
- Angervall L, Kindblom LG (1980) Clear-cell chondrosarcoma. A light and electron microscopic and histochemical study of two cases. Virchows Arch [A] 389:27–41 - PubMed
-
- Bianco P, Silvestrini B, Termine JD, Bonucci E (1988) Immunohistochemical localization of osteonectin in developing human and calf bone using monoclonal antibodies. Calcif Tissue Int 43:155–161 - PubMed
-
- Björnsson J, Unni K, Dahlin DC, Beabout JW, Sim FH (1984) Clear cell chondrosarcoma of bone. Am J Surg Pathol 8:223–230 - PubMed
-
- Bolander ME, Young MF, Fisher LW, Yamada Y, Termine JD (1988) Osteonectin cDNA sequence reveals potential binding regions for calcium and hydroxyapatite and shows homologies with both a basement membrane protein (SPARC) and a serine proteinase inhibitor (ovomucoid). Proc Natl Acad Sci USA 85:2919–2923 - PMC - PubMed
-
- Bosse A, Roessner A, Wuisman P, Jones D, Fisher LW, Vollmer E, Böcker W (1990) The impact of osteonectin for differential diagnosis of bone tumors. Path Res Pract 186:651–657 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous